1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Maytansine: new trials by email Literature Review of Maytansine trials Research Report on Maytansine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy, Standard of Care Chemotherapy - Salivary Gland Cancer, HER2 Gene Mutation | Phase 2 | Recruiting | Dana-Farber Cancer Institute | 37 | 2020-12-24 | 2026-04-13 |
Dana-Farber Cancer Institute (1)
United States (1)